Continuing our CPD initiative on hypertension, Valerie Ryan looks at the presentation from Dr Liam Glynn, Senior Lecturer in General Practice at NUI Galway, on the importance of treating to target and encouraging behavioural change.
Researchers in the Alimentary Pharmabiotic Centre in UCC have put forward a radically novel view of the biology of schizophrenia and more specifically its genetic basis, and their work may have significant implications for the development of new treatment strategies for the disorder.
Clinical trials carried out in the former East Germany in the second half of the 20th Century were not always with the full knowledge or understanding of participants with some questionable practices taking place, according to a paper published online in the Journal of Medical Ethics.
The management of overactive bladder (OAB) in the vulnerable elderly often poses significant management challenges.
New research published in The Lancet provides the first evidence of the medium-term to long-term safety and tolerability of transplanting human embryonic stem cells (hESCs) in humans.
The number of paediatric ENT outpatients has gradually increased over the past eight years, Gary Culliton reports in his latest Clinical Update. HIQA published clinical referral guidelines for grommets and tonsillectomies in 2013 in an attempt to reduce the number of inappropriate referrals from the community to hospital clinics.
Antibacterial resistance is a cause for major concern, according to a leading cystic fibrosis (CF) expert. World-leading CF experts, from Queen’s University Belfast, have called for greater research to address the issue of antibacterial resistance.
Continuing her CPD series from a new online initiative on hypertension, Valerie Ryan hears about the importance of starting from the right place on blood pressure measurement, from a talk by Prof Eoin O’Brien.
Cutting-edge research has been carried out at Queen’s University Belfast into eye disease.
A new initiative is aiming to make personalised medicine available to all European patients. The initiative is led by Prof Mark Lawler, Chair in Translational Cancer Genomics at the Queen’s University Belfast Centre of Cancer Research and Cell Biology (CCRCB).